Forecast: Import of Blood, Antisera, Vaccines, Toxins and Cultures to Italy

The import of Blood, Antisera, Vaccines, Toxins, and Cultures to Italy shows a consistent upward trend from 2024 through 2028. From 2023 to 2024, the value is anticipated to rise by a notable percentage, with subsequent years showing a steady increase by approximately 3% annually. By 2028, the import value is forecasted to reach 13.355 billion US dollars, indicating a compound annual growth rate (CAGR) over the five-year period.

Future trends to watch include advancements in biotech and pharmaceutical research, government health policies affecting import reliance, and global supply chain dynamics that could influence the pace of import growth. The demand driven by an aging population and increased focus on preventive healthcare will also impact these forecasts significantly.